News Conference News PCR London Valves 2024 Sustained Benefit With Pascal TEER Device at 2 Years: CLASP IID and MiCLASP Michael O'Riordan December 05, 2024
News Conference News PCR London Valves 2024 Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes Michael O'Riordan November 26, 2024
News Conference News PCR London Valves 2022 Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing Shelley Wood December 07, 2022
News Conference News PCR London Valves 2021 Good Results but Small Numbers With JenaValve Trilogy in Severe AR Michael O'Riordan November 26, 2021
News Conference News PCR London Valves 2021 MitraClip Cuts HF Hospitalizations in Real-World Registry: EXPAND Shelley Wood November 26, 2021
News Conference News PCR London Valves 2021 ‘Reasonable’ Results With TMVR for Mitral Regurgitation: CHOICE-MI Michael O'Riordan November 25, 2021
News Conference News PCR London Valves 2020 No Angina? No Benefit to PCI Pre-TAVR: ACTIVATION Shelley Wood November 26, 2020
News Conference News PCR London Valves 2019 Pulmonary Hypertension, Common in TAVR Patients, Linked to Lower Survival Michael O'Riordan November 26, 2019
News Conference News PCR London Valves 2018 Small Series Speak to Inching Progress in Off-Label or Expanded TAVR Applications Shelley Wood September 10, 2018
News Conference News PCR London Valves 2017 Pacemakers and Paravalvular Leak With Lotus: Updates From REPRISE III Shelley Wood September 27, 2017
News Conference News PCR London Valves 2016 TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients Shelley Wood September 20, 2016
News Conference News PCR London Valves 2016 MitraClip Feasible, Safe, and Produces Promising Early Results in Tricuspid Regurgitation Shelley Wood September 19, 2016